Subscribe to RSS - diabetes supplies

diabetes supplies

Providers mull mail-order bid


YARMOUTH, Maine – Will providers of diabetes testing supplies submit bids in the next phase of the national mail-order program? The verdict is mixed.

Mail-order program: OIG provides CMS with before, after picture


WASHINGTON – How has the national mail-order program for diabetes supplies affected brand choice?

CMS now has a before and after picture thanks to the Office of Inspector General (OIG).

In brief: Lawmakers introduce bid bill, SBA hosts stakeholders at hearing


WASHINGTON – Reps. Pat Tiberi, R-Ohio, and John Larson, D-Conn., have introduced a bill that would require providers to obtain bid bonds as part of future rounds of competitive bidding. H.R.

Is SMRC cherry-picking old claims?


YARMOUTH, Maine – StrategicHealthSolutions is digging deep in its latest round of post-pay reviews, industry stakeholders say: diabetes supply claims from 2011-2012.

Roche turns around diabetes sales


NEW YORK – Roche Diagnostics saw North American diabetes sales of $112 million for the first quarter of 2014, a 13% increase over the same period a year ago, according to news reports.

Audits take toll on contract supplier


FLETCHER, N.C. – All-States Medical Supply (ASM) in February laid off eight employees and company execs placed the blame squarely on audits.

Arriva buys rival company


CORAL SPRINGS, Fla. – Arriva Medical may have finally arrived at the top of the heap in the mail-order market for diabetes supplies.

Diabetes patients dominate complaint hotline


YARMOUTH, Maine – Ever since a national mail-order program for diabetes supplies kicked off July 1, beneficiaries have been complaining loud and clear—just not to CMS, say industry stakeholders.

Diabetes supplies: Want to reduce fraud? Step up technology use


WASHINGTON – A new report from the Office of Inspector General (OIG) on questionable billing for diabetes testing supplies drew sharp criticism from AAHomecare.

Report: Roche nixes plans to sell diabetes business


NEW YORK – Drugmaker Roche Holding AG is pulling back from plans to sell its blood glucose meter business, Reuters reports.